Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CASK interacting protein 2 (CASKIN2) is a large, multidomain neuronal scaffold protein characterized by six ankyrin repeats, a Src homology 3 (SH3) domain, and two sterile alpha motif (SAM) domains, along with extended proline-rich and conserved C-terminal regions[1][2][3][4]. It plays a key role in organizing postsynaptic protein complexes and modulating synaptic plasticity by nucleating large macromolecular assemblies at synaptic sites[1][3]. Although highly homologous to CASKIN1, CASKIN2 lacks a direct CASK interaction domain, leading to unique signaling roles. CASKIN2 binds talin and Abi1, linking integrin-mediated adhesion to cytoskeletal reorganization and migration, particularly in the context of some tumors[2]. In the nervous system, knockout studies indicate essential functions in memory, recognition, dendritic spine morphology, and synaptic receptor phosphorylation[1]. CASKIN2 can polymerize via its SAM domains into dimeric repeat units, a property thought to allow dynamic macromolecular assembly and organization at signaling sites[3][4]. Currently, no drugs are known to modulate CASKIN2, nor is it used as a diagnostic biomarker.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CASK interacting protein 2 (CASKIN2).